-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 5c ; Offers Guidance
-
-
-
-
-
-
-
Karyopharm Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) Tops Q1 EPS by 10c
-
-
-
-
-
-
-
Karyopharm Announces Phase 3 SIENDO Study Meets Primary Endpoint with Statistically Significant Increase in Progression-Free Survival in Patients with Advanced or Recurrent Endometrial Cancer
-
-
-
-
-
-
-
Karyopharm Reports Business Highlights and Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Karyopharm Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
-
973,681 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All